Antigenized antibodies expressing Vβ8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis

Journal of Immune Based Therapies and Vaccines

Volumn 2, Issue , 2004, Pages

  Musselli, Cristina ^a   Daverio Zanetti, Svetlana ^a   Zanetti, Maurizio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

EAE; Idiotype; Regulation; TCR

Indexed keywords

ALANYLSERYLSERYLASPARTYLSERYLSERYLASPARAGINYLTHREONYLGLUTAMIC ACID; ASPARTYLMETHIONYLGLYCYLHISTIDYLGLYCYLLEUCYLARGINYLLEUCYLISOLEUCYLHISTIDYLTYROSYLSERYLTYROSYLASPARTYLVALYLASPARAGINYLSERYLTHREONYLGLUTAMYLLYSYLGLYCINE; FREUND ADJUVANT; GLYCYLSERYLLEUCYLPROLYLGLUTAMYLLYSYLSERYLGLUTAMYLARGINYLSERYLGLUTAMYLASPARTYLGLUTAMYLASPARAGINYLPROLYLVALYLVALYLHISTIDYLPHENYLALANINE; IDIOTYPIC ANTIBODY; PEPTIDE; POLYPEPTIDE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG ANTIGENICITY; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMORAL IMMUNITY; IMMUNIZATION; NONHUMAN; PROTEIN CONFORMATION; PROTEIN EXPRESSION; RAT; RAT STRAIN; T LYMPHOCYTE; VACCINATION;

EID: 18144368148     PISSN: 14768518     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-8518-2-9     Document Type: Article

References (52)

1. Swanborg RH: Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunol Rev 2001, 184:129-135.
2. Hoffman PM, Gaston DD, Spitler LE: Comparison of experimental allergic encephalomyelitis induced with spinal cord, basic protein, and synthetic encephalitogenic peptide. Clin Immunol Immunopathol 1973, 1:364-371.
3. Richert JR, Kies MW, Alvord EJ: Enhanced transfer of experimental allergic encephalomyelitis with Lewis rat lymph node cells. J Neuroimmunol 1981, 1:195-203.
4. Polman CH, Dijkstra CD, Sminia T, Koetsier JC: Immunohistological analysis of macrophages in the central nervous system of Lewis rats with acute experimental allergic encephalomyelitis. J Neuroimmunol 1986, 11:215-222.
5. Acha-Orbea H, Mitchell DJ, Timmerman L, Wraith DC, Taich GS, Waldor MK, Zamvil S, McDevitt H, Steinman L: Limited heterogeneity of TcRs from lymphocytes mediating autoimmune encephalomyelitis aloows specific immune intervention. Cell 1988, 54:263-273.
6. Urban J, Kumar V, Kono DH, Gomez C, Horvath SJ, Clayton J, Ando DG, Sercarz EE, Hood L: Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 1988, 54:577-592.
7. Herber-Katz E: A new hierarchy of TCR specificity: Autoimmune diseases are defined by particular VaVb combinations and not by antigen specificity. Cold Spring Harbor Laboratory Press 1989, 54:875-878.
8. Steinman L, Solomon D, Lim M, Zamvil S, Sriram S: Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibody. Decreased accumulation of radiolabelled lymph node cells in the central nervous system. J Neuroimmunol 1983, 5:91-97.
9. Owhashi M, Herber-Katz E: Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein. J Exp Med 1988, 168:2153-2164.
10. Brostoff SW, Mason DW: Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J Immunol 1984, 133:1938-1942.
11. Welch AM, Swanborg RH: Characterization of suppressor cells involved in regulation of experimental allergic encephalomyelitis. Eur J Immunol 1976, 6:910-912.
12. Adda DH, Beraud E, Depieds R: Evidence for suppressor cells in Lewis rats experimental allergic encefalomyelitis. Eur J Immunol 1977, 7:620-625.
13. Beraud E, Varriale S, Farnarier C, Bernard D: Suppressor cells in Lewis rats with experimental allergic encephalomyelitis: prevention of the disease and inhibition of lymphocytes proliferation by suppressor cells or their products. Eur J Immunol 1982, 12:926-930.
14. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigenspecific triggering. Proc Natl Acad Sci U S A 1992, 89:421-425.
15. Ben-Nun A, Wekerle H, Cohen IR: Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 1981, 292:60-61?.
16. Rennie J: The body against itself. Scientific American 1990, 263:106-115.
17. Howell MD, Winters ST, Olee T, Powell HC, Carlo DJ, Brostoff SW: Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 1989, 246:668-670.
18. Vandenbark AA, Hashim G, Offern H: Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 1989, 341:541-544.
19. Offner H, Hashim GA, Vandenbark AA: T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science 1991, 251:430-432.
20. Stevens DB, Karpus WJ, Gould KE, Swanborg RH: Studies of V beta 8 T cell receptor peptide treatment in experimental autoimmune encephalomyelitis. J Neuroimmunol 1992, 37:123-129.
21. Desquenne-Clark L, Esch TR, Otvos L Jr, Heber-Katz E: T-cell receptor peptide immunisation leads to enhanced and chronic experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 1991, 88:7219-7223.
22. Matsumoto Y, Tsuchida M, Hanawa H, Abo T: T cell receptor peptide therapy for autoimmune encephalomyelitis: stronger immunization is necessary for effective vaccination. Cell Immunol 1994, 153:468-478.
23. Kumar V, Coulsell E, Ober B, Hubbard G, Sercarz E, Ward ES: Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells. J Immunol 1997, 159: 5150-5156.
24. Lanza P, Billetta R, Antonenko S, Zanetti M: Active immunity against the CD4 receptor using an antibody antigenized with residues 41-55 of the first extracellular domain. Proc Natl Acad Sci USA 1993, 90:11683-11687.
25. Zanetti M: Antigenized antibodies. Nature 1992, 355:466-477.
26. Sollazzo M, Hasemann CA, Meek KD, Glotz D, Capra JD, Zanetti M: Molecular characterization of the VH region of murine autoantibodies from neonatal and adult BALB/c mice. Eur J Immunol 1989, 19:453-457.
27. Sollazzo M, Billetta R, Zanetti M: Expression of an exogenous peptide epitope genetically engineereed in the variable domain of an immunoglobulin: implications for antibody and peptide folding. Protein Eng 1990, 4:215-220.
28. Morrison S: Transfectomas provide novel chimeric antibodies. Science 1985, 229:1202-1207.
29. Billetta R, Zanetti M: Ligand expression using antigenization of antibody: Principle and methods. ImmunoMethods 1992, 1:41-51.
30. Hashim GA, Carvalho EF, Sharpe RD: Definition and synthesis of the essential amino acid sequence for experimental allergic encephalomyelitis in Lewis rats. J Immunol 1978, 121: 665-670.
31. Billetta R, Hollingdale RM, Zanetti M: Immunogenicity of an engineered internal image antibody. Proc Natl Acad Sci USA 1991, 88:4713-4717.
32. Lenert P, Kroon D, Spiegelberg H, Golub ES, Zanetti M: Human CD4 binds immunoglobulins. Science 1990, 248: 1639-1643.
33. Gold DP, Offner H, Sun D, Wiley S, Vandenbark AA, Wilson DB: Analysis of T cell receptor beta chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3. J Exp Med 1991, 174:1467-1476.
34. Ben-Nun A, Ron Y, Cohen IR: Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy or ageing. Nature 1980, 288:389-390.
35. Karpus WJ, Gould KE, Swanborg RH: CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur J Immunol 1992, 22:1757-1763.
36. Koh DR, Ho A, Rahemtulla A, Penninger J, Mak TW: Experimental allergic encephalomyelitis (EAE) in mice lacking CD4+ T cells. Eur J Immunol 1994, 24:2250-2253.
37. Jiang H, Zhang SI, Pernis B: Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 1992, 256:1213-1215.
38. Koh DR, Fung LW, Ho A, Gray D, Acha OH, Mak TW: Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 1992, 256:1210-1213.
39. Sun D, Qin Y, Chluba J, Epplen JT, Wekerle H: Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 1988, 332:843-845.
40. Heber-Katz E, Acha-Orbea H: The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. Immunol Today 1989, 10:164-169.
41. Kumar V, Sercarz E: An integrative model of regulation centered on recognition of TCR peptide/MHC complexes. Immunol Rev 2001, 182:113-121.
42. Hashim GA, Vandenbark AA, Galang AB, Diamanduros T, Carvalho E, Srinivasa J, Jones R, Vainiene M, Morrison WJ, Offner H: Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis. J Immunol 1990, 144:4621-4627.
43. Matsumoto Y, Tsuchida M, Hanawa H, Abo T: Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody. Immunology 1994, 81:1-7.
44. Zhou SR, Whitaker JN: Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies. J Immunol 1993, 150:1629-1642.
45. Jerne NK, Roland J, Cazenave PA: Recurrent idiotypes and internal images. EMBO J 1982, 1:243-247.
46. McKearn TJ, Hamada Y, Stuart FP, Fitch FW: Anti-receptor antibody and resistance to graft-versus-host disease. Nature 1974, 251:648-650.
47. Binz H, Wigzell H: Successful induction of specific tolerance to transplantation antigens using autoimmunisation against the recipient's own natural antibodies. Nature 1976, 262: 294-295.
48. Binz H, Wigzell H: Specific transplantation tolerance induced by autoimmunization against the individual's own, naturally occurring idiotypic, antigen-binding receptors. J Exp Med 1976, 144:1438-1457.
49. Kyte J, Doolittle RF: A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982, 157:105-132.
50. Sun D: Synthetic peptides representing sequence 39 to 59 of rat V beta 8 TCR fail to elicit regulatory T cells reactive with V beta 8 TCR on rat encephalitogenic T cells. Cell Immunol 1992, 141:200-210.
51. Kawano Y, Sasamoto Y, Vacchio MS, Hodes RJ, Gery I: Immune responses against self-TCR peptides. Cell Immunol 1994, 159:235-245.
52. Paterson PY, Harwin SM: Suppression of allergic encephalomyelitis in rats by means of antibody serum. J Exp Med 1963, 117:755-780.